Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients.
about
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Sirukumab in rheumatoid arthri ...... cy study in Japanese patients.
@en
Sirukumab in rheumatoid arthri ...... cy study in Japanese patients.
@nl
type
label
Sirukumab in rheumatoid arthri ...... cy study in Japanese patients.
@en
Sirukumab in rheumatoid arthri ...... cy study in Japanese patients.
@nl
prefLabel
Sirukumab in rheumatoid arthri ...... cy study in Japanese patients.
@en
Sirukumab in rheumatoid arthri ...... cy study in Japanese patients.
@nl
P2093
P2860
P1476
Sirukumab in rheumatoid arthri ...... cy study in Japanese patients.
@en
P2093
Benjamin Hsu
Hisashi Yamanaka
Masayoshi Harigai
Ryo Tamamura
Toshikazu Nakano
Yoshifumi Ukyo
Yoshiya Tanaka
Yuichi Kato
P2860
P2888
P356
10.1186/S13075-018-1536-9
P577
2018-03-07T00:00:00Z
P6179
1101373669